Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07794813Recruiting
Imaging agent for clearer tumor removal in oral cancer surgery
This study tests a new imaging agent that helps surgeons see oral tumors more clearly during surgery. It aims to improve the accuracy of tumor removal.
Kunming, YunnanAges 18–75 - NCT07796217RecruitingPhase 4
Comparing blood thinners after a heart attack
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07799922Recruiting
Liver cancer treatment after immunotherapy
This trial tests a new procedure called IRE (a way to destroy tumors) for people with liver cancer that has not responded well to initial immunotherapy. It aims to help when surgery is not possible due to the tumor's size or location.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07795528Recruiting
Blood test to monitor colon cancer after surgery
This trial uses a simple blood test to look for tiny bits of tumor DNA after colon cancer surgery. If found, it may help doctors catch any remaining cancer early and guide further treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07794514Recruiting
Comparing two drugs for liver graft-versus-host disease
This trial compares two medications, belumosudil and ruxolitinib, to see which one works better for a type of graft-versus-host disease (GVHD) that affects the liver after a stem cell transplant. GVHD happens when donor cells attack the patient's body, and this study focuses on patients whose liver GVHD has not improved with steroids or has gotten worse. The study aims to find a more effective treatment to control this condition.
Hangzhou, ZhejiangAges 12 years+ - NCT07795723Recruiting
Biopsy method comparison for diagnosing prostate cancer
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
Nanjing, JiangsuAges 19 years+ - NCT07799818Recruiting
Joint replacement study for hip or knee
This study looks at how well hip or knee replacements work. If you are already scheduled for a replacement or a revision (a second replacement), you may be able to join.
Bonn, North Rhine-WestphaliaAges 18–100 - NCT07793500RecruitingEarly Phase 1
Nebulized drug for lung metastases from solid tumors
This study tests a new drug given as a mist you breathe in, for people whose cancer has spread to the lungs. The goal is to see if it can shrink tumors or slow their growth.
BeijingAges 18–75 - NCT07798778RecruitingEarly Phase 1
New drug for advanced prostate cancer that has stopped responding to hormone therapy
This trial tests a new drug called SRT-017 for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drug targets a marker on cancer cells (PSMA) and may help slow the disease. The study will check if it is safe and effective.
Wuxi, JiangsuAges 18 years+ - NCT07794098Recruiting
Sexual health support for gynecologic cancer patients
This study tests a mobile app that provides sexual health information and support to women recently diagnosed with gynecologic cancer. It aims to help you manage concerns about intimacy and sexuality during your cancer treatment.
Taoyuan, GuishanAges 20–70 - NCT07799519RecruitingPhase 2
Finerenone after heart procedure to lower atrial fibrillation return
This trial tests whether taking finerenone after a heart procedure to fix irregular heartbeat can help prevent atrial fibrillation from coming back. It's for people having their first such procedure and aims to improve long-term heart rhythm health.
TainanAges 18–80 - NCT07795437Recruiting
New PET imaging tracer for liver cancer
This study tests a new imaging tracer to better see liver cancer on PET scans, which might help doctors find or monitor tumors more accurately.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07797816RecruitingPhase 2
Targeted drug combo with radiation for advanced bile duct cancer
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug, followed by targeted radiation, in people with bile duct or gallbladder cancer that cannot be removed with surgery. The goal is to see if this approach can shrink tumors and improve outcomes.
Nanjing, JiangsuAges 18–80 - NCT07799974Recruiting
Tracking fatigue and activity in lung cancer
This study follows patients with advanced lung cancer to see how fatigue and physical activity change during treatment. It aims to help improve support for symptoms like tiredness.
Ghent, Oost-VlaanderenAges 18 years+ - NCT07799363Recruiting
Heart imaging test comparison for patients getting a new heart valve
This study compares two heart imaging scans to see if a newer CT scan works as well as an MRI for checking blood flow and heart tissue in people having a heart valve replacement. It may help improve care for patients with aortic stenosis.
Huddinge, Stockholm CountyAges 60 years+ - NCT07794995Recruiting
Acupressure band for period pain in college students
This trial tests whether wearing an acupressure band can reduce period pain in college students. It might help you if you have painful periods without any other medical condition causing the pain.
Taichung, Taichung CityAges 20–24 - NCT07796880RecruitingPhase 2
Study of a new drug with hormone therapy before breast cancer surgery
This trial tests a new drug called culmerciclib when given with hormone therapy before breast cancer surgery. The goal is to see if this combination can shrink tumors and improve outcomes for patients with hormone-receptor-positive, HER2-negative breast cancer.
Guangzhou, GuangdongAges 18–70 - NCT07799636Recruiting
Early warning for breathing problems after surgery
This study tests a new way to predict breathing problems soon after surgery by looking at ventilator waveforms. If successful, it could help doctors spot issues earlier and provide better care.
Chengdu, SichuanAges Any age - NCT07798180Recruiting
Ear stimulation for belly pain in teens
This study tests a small earpiece that sends gentle signals to help reduce belly pain in teens with disorders of the gut-brain interaction. It may offer a drug-free way to manage pain.
Columbus, OhioAges 12–18 - NCT06478472Recruiting
Orelabrutinib plus rituximab for marginal zone lymphoma
This trial tests a combination of two targeted therapies—oralebrutinib (a pill that blocks a protein in cancer cells) and rituximab (an antibody infusion)—for people with marginal zone lymphoma that has returned or cannot be treated with local therapies. The goal is to see if this combo works well and is safe.
Xiamen, FujianAges 18 years+ - NCT06524037Recruiting
Metabolic profiles and chronic disease study
This study looks at how your metabolic health (like blood sugar and cholesterol) relates to chronic diseases and cancer. If you are an adult who has already had a health screening, you may be able to join.
Chongqing, Chongqing MunicipalityAges 18–85 - NCT06525909Recruiting
Immune status in chronic hepatitis B
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
Wuhan, HubeiAges 18–50 - NCT05874674Recruiting
Testing nafamostat to reduce bleeding risk during dialysis
This pilot study tests whether nafamostat is safe for people on hemodialysis who have a high risk of bleeding. It may help clinicians find safer ways to manage blood clotting medicines during dialysis.
Wŏnju, KangwondoAges 18–99 - NCT04725422Recruiting
Registry for children with nonbacterial bone inflammation
This study collects medical information (and imaging results) from children and teens with nonbacterial bone inflammation. It may help doctors better understand how this condition looks on scans and how it’s diagnosed, especially to rule out infection or cancer.
Seattle, WashingtonAges Up to 21 years
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,157 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.